Treace Medical Concepts (TMCI) Cash & Equivalents (2020 - 2026)
Treace Medical Concepts' (TMCI) quarterly Cash & Equivalents came in at $9.5 million in Q1 2026, down 28.63% YoY from $13.4 million in Q1 2025, and down 10.87% on a QoQ basis from $10.7 million in Q4 2025.
Treace Medical Concepts (TMCI) Cash & Equivalents (2020 - 2026) Analysis & Trends
Treace Medical Concepts (TMCI) has 7 years of Cash & Equivalents data on file, last reported at $9.5 million in Q1 2026.
- Quarterly Cash & Equivalents fell 28.63% year-over-year to $9.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.5 million (down 28.63% YoY) and the FY2025 annual result came in at $10.7 million, down 5.66% from the prior year.
- Cash & Equivalents retreated to $9.5 million in Q1 2026, from $10.7 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $101.5 million in Q2 2022 to a low of $7.3 million in Q3 2023.
- A 5-year average of $23.9 million and a median of $12.1 million in 2023 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2022 — Cash & Equivalents jumped 507.25% — and 2023, when it sank 88.15%.
- Tracing TMCI's Cash & Equivalents over 5 years: stood at $19.5 million in 2022, then plunged by 33.33% to $13.0 million in 2023, then decreased by 12.57% to $11.4 million in 2024, then dropped by 5.66% to $10.7 million in 2025, then slipped by 10.87% to $9.5 million in 2026.
- The last three Cash & Equivalents figures came in at $9.5 million (Q1 2026), $10.7 million (Q4 2025), and $7.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Treace Medical Concepts | 281.67 Mn | 236.05 Mn | 35.61 Mn | 12.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.61 Mn |
| Mar 31, 2026 | 9.54 Mn |
| Dec 31, 2025 | 10.71 Mn |
| Sep 30, 2025 | 7.69 Mn |
| Jun 30, 2025 | 8.05 Mn |
| Mar 31, 2025 | 13.37 Mn |
| Dec 31, 2024 | 11.35 Mn |
| Sep 30, 2024 | 12.11 Mn |
| Jun 30, 2024 | 18.18 Mn |
| Mar 31, 2024 | 9.33 Mn |
| Dec 31, 2023 | 12.98 Mn |
| Sep 30, 2023 | 7.28 Mn |
| Jun 30, 2023 | 12.04 Mn |
| Mar 31, 2023 | 29.61 Mn |
| Dec 31, 2022 | 19.47 Mn |
| Jun 30, 2022 | 101.53 Mn |
| Mar 31, 2022 | 98.48 Mn |
| Dec 31, 2021 | 105.83 Mn |
| Sep 30, 2021 | 109.46 Mn |
| Jun 30, 2021 | 119.62 Mn |